Life Sciences Company Microbix Announces Investor Conference
What happened
Microbix Biosystems Inc., a life sciences company, announced it will present to investors at the Cantech Investment Conference on October 8, 2026. The company, which has 120 employees and fiscal 2025 revenues of C$18.6 million, specializes in products that support diagnostic testing and laboratory quality assurance. CEO Cameron Groome will present and hold one-on-one meetings with growth company investors during the conference, with presentation slides available on the company website.
From pr-inside.com
Why it matters
The announcement provides visibility into Microbix's business model as a provider of proprietary antigens used by approximately 100 diagnostics manufacturers. The conference offers potential investors insight into the company's operations and financial disclosures.
From pr-inside.com
Who's involved
Keep exploring
The entities involved
-
Toronto Stock Exchange
stock exchange in Canada
Related events
- Lightspeed, a company based in Montréal, is the subject of market commentary regarding its performance, which is traded on the Toronto Stock Exchange.
- Premium Brands Holdings Corporation used the Toronto Stock Exchange facilities for share purchases on October 14, 2026.
- TMX Group manages TSX operations and is seeking senior equities marketplace status in Canada.
- Graham Mackenzie was appointed as the Managing Director of the Toronto Stock Exchange on May 28, 2026.